Virtu Financial’s TScan Therapeutics TCRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$17K	Buy	11,388 +365	+3%	+$545	﹤0.01%	1271
2025 Q1	$15K	Buy	+11,023	New	+$15K	﹤0.01%	1144
2024 Q1	–	Sell	-18,418	Closed	-$107K	–	2083
2023 Q4	$107K	Buy	+18,418	New	+$107K	0.01%	1017